一种多价值DNA纳米粒子/杂物分子模式,用于调节瘤微环境中的蛋白质-蛋白质相互作用
Jessica A Roman1, Michael Y Girgis2, Rocìo S Prisby1
1Center for Applied Proteomics and Molecular Medicine, 19020 George Mason Circle, Manassas, VA, 20110, USA.
Advanced nanobiomed research
|September 27, 2024
概括
研究人员开发了一种新的DNA支架类疗法,以阻止IL-33/ST2通路,通过克服免疫耐受性来改善固体瘤的免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 免疫疗法在固体瘤中表现出有限的疗效,原因是瘤微环境中的免疫逃避.
- 针对蛋白质与蛋白质相互作用 (PPI) 对于免疫激活至关重要,但对于非酶性PPI来说具有挑战性.
- IL-33/ST2信号轴有助于瘤耐受性和免疫治疗耐药性.
研究的目的:
- 开发一种用于准蛋白质-蛋白质相互作用的新型分子模式.
- 创建一个针对IL-33/ST2信号轴的原型,以增强抗瘤免疫力.
主要方法:
- 设计了一个合成的多价值分子平台,使用DNA支架上的小干扰.
- 开发出模仿IL-33/ST2共受体相互作用热点残留物的.
- 利用细胞模型来评估结合亲和力,信号传导抑制和选择性.
主要成果:
- 这种DNA架构的分子有效地与IL-33/ST2结合,结合亲和力 (Kd) 为110nM.
- 该分子在高纳米分子度下,在细胞模型中取消IL-33/ST2信号传导.
- 在类似的蛋白质与蛋白质相互作用中,对目标复合体表现出极好的选择性.
结论:
- 合成分子模式为针对具有挑战性的蛋白质-蛋白质相互作用提供了一个有希望的策略.
- 这种方法有效地破坏IL-33/ST2通路,这是瘤耐受性的关键媒介.
- 开发的平台有可能改善固体瘤的免疫治疗结果.
相关概念视频
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K